FONT-SIZE Plus   Neg

Nu Skin Enterprises Expects Q4 Revenue To Rise By 19% YoY - Quick Facts

Nu Skin Enterprises, Inc. (NUS) Wednesday announced anticipated results for the fourth quarter. The company currently expects fourth-quarter per share earnings to be in a range between $0.94 and $0.96. Quarterly revenue is expected to touch about $588 million, representing a increase of 19 percent from the prior year. The company added that the impact of foreign currency exchange on revenue shall be negligible for the latest fourth quarter.

On average, 8 analysts polled by Thomson Reuters expect the company to earn $0.83 per share on revenues of 531.57 million for the quarter. Analysts' estimates typically exclude special items.

Truman Hunt, president and chief executive stated, "As a result of the efforts of our sales leaders and corporate personnel around the world, revenue growth will be 19 percent in the fourth quarter, surpassing prior revenue guidance by $58 million."

In addition, Nu Skin repurchased $200 million of its stock during the year, constituting nearly 7 percent of its total shares outstanding.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Trade NUS now with 
Follow RTT